BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21705452)

  • 21. [Deciphering functional activity of TLX homeodomain oncogenes in T-ALL: a clue for a differentiating therapy?].
    Asnafi V; Ferrier P
    Med Sci (Paris); 2012; 28(8-9):708-10. PubMed ID: 22920872
    [No Abstract]   [Full Text] [Related]  

  • 22. Chimaeric oncoproteins resulting from chromosomal translocations in acute lymphoblastic leukaemia.
    Hunger SP; Cleary ML
    Semin Cancer Biol; 1993 Dec; 4(6):387-99. PubMed ID: 8142624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comprehensive inventory of TLX1 controlled long non-coding RNAs in T-cell acute lymphoblastic leukemia through polyA+ and total RNA sequencing.
    Verboom K; Van Loocke W; Volders PJ; Decaesteker B; Cobos FA; Bornschein S; de Bock CE; Atak ZK; Clappier E; Aerts S; Cools J; Soulier J; Taghon T; Van Vlierberghe P; Vandesompele J; Speleman F; Durinck K
    Haematologica; 2018 Dec; 103(12):e585-e589. PubMed ID: 29954933
    [No Abstract]   [Full Text] [Related]  

  • 24. [Acute T cells lymphoblastic leukemia with a t(1;19)(q23;p13) and E2A-PBX1 in an adult: one case report and literature review].
    He GS; Zhang XH; Yao L; Zhang R; Chen ZX; Wu DP; Sun AN; Jin ZM; Qiu HY; Hu XH
    Zhonghua Xue Ye Xue Za Zhi; 2009 Oct; 30(10):675-7. PubMed ID: 19954663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel TLX1-driven T-ALL zebrafish model: comparative genomic analysis with other leukemia models.
    Loontiens S; Vanhauwaert S; Depestel L; Dewyn G; Van Loocke W; Moore FE; Garcia EG; Batchelor L; Borga C; Squiban B; Malone-Perez M; Volders PJ; Olexiouk V; Van Vlierberghe P; Langenau DM; Frazer JK; Durinck K; Speleman F
    Leukemia; 2020 Dec; 34(12):3398-3403. PubMed ID: 32591643
    [No Abstract]   [Full Text] [Related]  

  • 26. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia.
    Ferrando AA; Neuberg DS; Dodge RK; Paietta E; Larson RA; Wiernik PH; Rowe JM; Caligiuri MA; Bloomfield CD; Look AT
    Lancet; 2004 Feb; 363(9408):535-6. PubMed ID: 14975618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T cell receptor genotyping and HOXA/TLX1 expression define three T lymphoblastic lymphoma subsets which might affect clinical outcome.
    Baleydier F; Decouvelaere AV; Bergeron J; Gaulard P; Canioni D; Bertrand Y; Lepretre S; Petit B; Dombret H; Beldjord K; Molina T; Asnafi V; Macintyre E
    Clin Cancer Res; 2008 Feb; 14(3):692-700. PubMed ID: 18245528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Of mice and men: how an oncogene transgresses the limits and predisposes to T cell acute lymphoblastic leukemia.
    Hoang T
    Sci Transl Med; 2010 Mar; 2(21):21ps10. PubMed ID: 20374994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. V(D)J targeting mistakes occur at low frequency in acute lymphoblastic leukemia.
    Vanura K; Vrsalovic MM; Le T; Marculescu R; Kusec R; Jäger U; Nadel B
    Genes Chromosomes Cancer; 2009 Aug; 48(8):725-36. PubMed ID: 19455608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. scl, a gene frequently activated in human T cell leukaemia, does not induce lymphomas in transgenic mice.
    Robb L; Rasko JE; Bath ML; Strasser A; Begley CG
    Oncogene; 1995 Jan; 10(1):205-9. PubMed ID: 7824274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The DN2 Myeloid-T (DN2mt) Progenitor is a Target Cell for Leukemic Transformation by the TLX1 Oncogene.
    Zweier-Renn LA; Riz I; Hawley TS; Hawley RG
    J Bone Marrow Res; 2013 Feb; 1():. PubMed ID: 25309961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular genetics of acute lymphoblastic leukemia.
    Teitell MA; Pandolfi PP
    Annu Rev Pathol; 2009; 4():175-98. PubMed ID: 18783329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ectopic TLX1 expression accelerates malignancies in mice deficient in DNA-PK.
    Krutikov K; Zheng Y; Chesney A; Huang X; Vaags AK; Evdokimova V; Hough MR; Chen E
    PLoS One; 2014; 9(2):e89649. PubMed ID: 24586935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of the novel AML1 fusion partner gene, LAF4, a fusion partner of MLL, in childhood T-cell acute lymphoblastic leukemia with t(2;21)(q11;q22) by bubble PCR method for cDNA.
    Chinen Y; Taki T; Nishida K; Shimizu D; Okuda T; Yoshida N; Kobayashi C; Koike K; Tsuchida M; Hayashi Y; Taniwaki M
    Oncogene; 2008 Apr; 27(15):2249-56. PubMed ID: 17968322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL.
    Della Gatta G; Palomero T; Perez-Garcia A; Ambesi-Impiombato A; Bansal M; Carpenter ZW; De Keersmaecker K; Sole X; Xu L; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Meijerink JP; Califano A; Ferrando AA
    Nat Med; 2012 Feb; 18(3):436-40. PubMed ID: 22366949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MYC fails to efficiently shape malignant transformation in T-cell acute lymphoblastic leukemia.
    Loosveld M; Bonnet M; Gon S; Montpellier B; Quilichini B; Navarro JM; Crouzet T; Goujart MA; Chasson L; Morgado E; Picard C; Hernandez L; Fossat C; Gabert J; Michel G; Nadel B; Payet-Bornet D
    Genes Chromosomes Cancer; 2014 Jan; 53(1):52-66. PubMed ID: 24249258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. E2a/Pbx1 oncogene inhibits terminal differentiation but not myeloid potential of pro-T cells.
    Bourette RP; Grasset MF; Mouchiroud G
    Oncogene; 2007 Jan; 26(2):234-47. PubMed ID: 16819510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia.
    Sanda T; Leong WZ
    Exp Hematol; 2017 Sep; 53():7-15. PubMed ID: 28652130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.